Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer.
Giani C, Valerio L, Bongiovanni A, Durante C, Grani G, Ibrahim T, Mariotti S, Massa M, Pani F, Pellegriti G, Porcelli T, Salvatore D, Tavarelli M, Torlontano M, Locati L, Molinaro E, Elisei R. Giani C, et al. Among authors: durante c. Thyroid. 2021 Feb;31(2):224-232. doi: 10.1089/thy.2020.0276. Epub 2020 Oct 22. Thyroid. 2021. PMID: 32907501
Nonsurgical approaches to the management of thyroid nodules.
Filetti S, Durante C, Torlontano M. Filetti S, et al. Among authors: durante c. Nat Clin Pract Endocrinol Metab. 2006 Jul;2(7):384-94. doi: 10.1038/ncpendmet0215. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16932321 Review.
Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
Montesano T, Durante C, Attard M, Crocetti U, Meringolo D, Bruno R, Tumino S, Rubello D, Al-Nahhas A, Colandrea M, Maranghi M, Travascio L, Ronga G, Torlontano M. Montesano T, et al. Among authors: durante c. Biomed Pharmacother. 2007 Sep;61(8):468-71. doi: 10.1016/j.biopha.2007.04.001. Epub 2007 May 22. Biomed Pharmacother. 2007. PMID: 17553654
Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients.
Torlontano M, Durante C, Torrente I, Crocetti U, Augello G, Ronga G, Montesano T, Travascio L, Verrienti A, Bruno R, Santini S, D'Arcangelo P, Dallapiccola B, Filetti S, Trischitta V. Torlontano M, et al. Among authors: durante c. J Clin Endocrinol Metab. 2008 Mar;93(3):910-3. doi: 10.1210/jc.2007-1067. Epub 2007 Dec 11. J Clin Endocrinol Metab. 2008. PMID: 18073314
Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family.
Mastroianno S, Torlontano M, Scillitani A, D'Aloiso L, Verrienti A, Bonfitto N, De Bonis A, D'Agruma L, Muscarella LA, Guarnieri V, Dicembrino F, Maranghi M, Durante C, Filetti S. Mastroianno S, et al. Among authors: durante c. Endocrine. 2011 Dec;40(3):481-5. doi: 10.1007/s12020-011-9501-2. Epub 2011 Jun 17. Endocrine. 2011. PMID: 21678021
Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement?
Durante C, Montesano T, Attard M, Torlontano M, Monzani F, Costante G, Meringolo D, Ferdeghini M, Tumino S, Lamartina L, Paciaroni A, Massa M, Giacomelli L, Ronga G, Filetti S; PTC Study Group. Durante C, et al. J Clin Endocrinol Metab. 2012 Aug;97(8):2748-53. doi: 10.1210/jc.2012-1123. Epub 2012 Jun 7. J Clin Endocrinol Metab. 2012. PMID: 22679061
Papillary thyroid cancer: time course of recurrences during postsurgery surveillance.
Durante C, Montesano T, Torlontano M, Attard M, Monzani F, Tumino S, Costante G, Meringolo D, Bruno R, Trulli F, Massa M, Maniglia A, D'Apollo R, Giacomelli L, Ronga G, Filetti S; PTC Study Group. Durante C, et al. J Clin Endocrinol Metab. 2013 Feb;98(2):636-42. doi: 10.1210/jc.2012-3401. Epub 2013 Jan 4. J Clin Endocrinol Metab. 2013. PMID: 23293334
308 results